Momenta Pharmaceuticals ( MNTA ) 2012 Citi Global Health Care Conference Feb 28, 2012 11:00 AM ET Executives Analyst Presentation Unidentified Company Representative Compare to: Previous Statements by MNTA » Momenta Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript » Momenta Pharmaceuticals CEO Hosts Investor Conference Call to Discuss Follow-On Biologics Collaboration with Baxter (Transcript) » Momenta Pharmaceuticals' Management Presents at Deutsche Bank BioFEST 2011 - Event Transcript I'd like to draw your attention to our safe harbor statement and risk factors included in our SEC filings. Momenta Pharmaceuticals is using innovative characterization tools, methods for determining structure and process and applying patented methods and approaches to identifying the structure, the process and the biology for complex mixture drugs and we do that in order to develop a portfolio of both generic and novel products.